Member Exclusive News

Alzheimer’s disease prevented by pharmacological chaperone therapy in mice

Pharmacological chaperones have proved successful in mediating the activity of VPS35 in mice models of Alzheimer’s disease – resulting in a reduction of tau and amyloid beta aggregates when compared to untreated mice.

Please sign in or register for FREE

No comments yet.